The Community Resource in Targeted Therapies
Driving Knowledge. Empowering Change. Optimizing Outcomes.
ONCAlert | Upfront Therapy for mRCC
Multiple Myeloma Case Studies

Case Studies: Multiple Myeloma With Symptomatic Progression

In this case-based interview, Sagar Lonial, MD, reviews the management of multiple myeloma in a frail elderly patient with progressive multiple myeloma and of a second patient with high-risk disease.

Multiple Myeloma With Symptomatic Progression: Case 2

Multiple Myeloma With High-Risk Features

July 2017

  • A 54-year-old Caucasian male presented to his physician with anemia
  • Bone marrow biopsy showed 43% plasma cells
  • FISH t(11:14), deletion 13, deletion 17p
  • Diagnosis: multiple myeloma with high-risk features
  • The patient was treated with lenalidomide, bortezomib, and dexamethasone (VRD) followed by autologous stem cell transplant, and bortezomib maintenance
Copyright © TargetedOnc 2018 Intellisphere, LLC. All Rights Reserved.